The Optimization of Iron Bioavailability of Supplements Using Hepcidin Levels in Humans
NCT02050932
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
32
Enrollment
OTHER
Sponsor class
Conditions
Iron Deficiency
Interventions
DIETARY_SUPPLEMENT:
60 mg Fe as FeSO4 with stable isotopic labels
Sponsor
Swiss Federal Institute of Technology